Abstract: Human YPEL4 is a member of YPEL family. It contains a Yippee domain, which is a putative zinc-finger-like, metal-binding domain. The human YPEL4 gene maps to chromosome 11q12.1, is ubiquitously expressed in adult tissues, and encodes a nuclear protein of 127 amino acids, the function of which remains unknown. To gain insights into the cellular function of this protein, we searched for YPEL4-interacting proteins using a yeast two-hybrid screen. The major vault protein (MVP), a lung resistance associated protein, was identified as a binding partner of YPEL4. The interaction between YPEL4 and MVP in mammalian cells was further demonstrated by a series of biochemical assays including the mammalian two-hybrid assay, GST pull-down assay, co-immunoprecipitation assay, and immunocytochemistry. Using a reporter system, we found that MVP can inhibit YPEL4's ability to activate Elk-1 in the MAPK signaling pathway. This study provides new clues for understanding the molecular mechanism of YPEL4 in cell division and signal transduction pathways and should be helpful for understanding molecular functions of the YPEL family.
Introduction
The YPEL gene family was characterized as the first highly conserved family of genes coding for proteins containing putative zinc-finger-like metal-binding domains, and is found in a wide spectrum of eukaryotic species. The human YPEL gene family consists of 5 genes (YPEL1 through YPEL5). Human YPEL1 was described as an ortholog of mouse Ypel1, which is homologous to the Drosophila gene yippee (Farlie et al. 2001) . By comprehensive sequence analysis of human chromosome 22, Hosono et al. (2004) cloned the other members of the human YPEL gene family and established a consensus sequence of C-X2-CX19-G-X3-L-X5-N-X13-G-X8-C-X2-C-X4-GWXY-X10-K-X6-E for all of the YPEL family proteins. All human YPEL proteins are located close to the centrosome and nucleolus during interphase and at several dot-like structures around the mitotic apparatus during mitosis (Hosono et al. 2004) . Conservation of the zinc-finger-like metal-binding domains and the subcellular localization suggests important roles of YPEL genes in the cell life cycle . Although YPEL1 induces epitheliallike morphology in fibroblasts (Farlie et al. 2001) , the mo-lecular mechanisms for the other members of the human YPEL gene family have not yet been elucidated.
Mitogen-activated protein kinase (MAPK) pathways are major cell cycle signaling systems involved in the regulation of cell proliferation, differentiation, damage repair mechanisms, and death. MAPK pathways transduce extracellular signals into intracellular responses, and its activity is regulated through a 3-tiered cascade composed of a MAPK, MAPK kinase (MAPKK, MKK or MEK) , and a MAPKK kinase or MEK kinase (MAPKKK or MEKK) . In mammals, there are at least 4 distinct groups of MAPKs: extracellular signal-related kinases ERK1 and ERK2), Jun amino-terminal kinases (JNK1, JNK2, and JNK3), p38 proteins (p38a, p38b, andp38c), and ERK5 (Whitmarsh and Davis 2000) . The most studied targets of MAPK signaling pathways are the ERK cascades, which regulate transcription of immediate early gene expression. The MAPKs at the end of the ERK cascades phosphorylate their target proteins, such as transcription factors (Elk-1, C-jun), which regulate immediate early gene expression through binding to the serum response element (SRE) (Gille et al. 1995) .
YPEL4 is a typical member of YPEL family. To date, no YPEL4-interacting factor has been reported. To search for YPEL4-interacting proteins, we used YPEL4 as the bait and screened a human brain cDNA library in a yeast two-hybrid system. We identified MVP involved in the MAPK signal pathway as a protein partner of YPEL4. The interaction of the two proteins was confirmed by mammalian two-hybrid reporter assay, co-localization assays, co-immunoprecipitation, and GST pull-down assay. Furthermore, using RNAi analysis and luciferase reporter assay, we demonstrated that MVP resulted in suppression of YPEL4-mediated Elk-1 activation.
Materials and methods

Vector construction
For yeast two-hybrid screening, full-length cDNA of YPEL4 was ligated in frame with the GAL4 DNA-binding domain of the pGBKT7 vector resulting in pGBKT7-YPEL4. For mammalian two-hybrid reporter assays, the full-length cDNA of YPEL4 was cloned into the mammalian expression plasmid pCMV-BD, forming a YPEL4 expression vector, pCMV-BD-YPEL4, while the cDNA fragment of MVP was cloned into the mammalian expression plasmid pCMV-AD, forming an MVP expression vector, pCMV-AD-MVP. To co-locate YPEL4 and MVP in cells, vector EGFPN1 was used to construct vectors expressing YPEL4, and vector pCMV-Tag2B for MVP. Vector pGEX-4T-1 was used to construct vectors expressing GST-YPEL4 fusion proteins for GST pull-down assay. For immunoprecipitation assays, vector pCMV-Tag2B and vector pCMV-Myc were used to construct vectors expressing YPEL4 and MVP, respectively. Vector pSuper was used to investigate the effects of RNA interference. The full-length cDNA of YPEL4 was cloned into the mammalian expression plasmid pCMVTag2B, forming a Flag-tagged YPEL4 expression vector, pCMV-Flag-YPEL4, and the cDNA fragment of MVP was also cloned into pCMV-Tag2B vector for the luciferase reporter assay.
Yeast two-hybrid screen
A human brain cDNA library (Clontech) in frame with the GAL4 activation domain in the vector pACT2 was used to screen YPEL4-interacting clones. The yeast strain AH109 was transformed with a pGBKT7-YPEL4 bait construct and selected in synthetic dropout medium lacking Trp. The baitcontaining AH109 cells were subsequently transformed with the human brain cDNA library (Clontech), and transformants were selected by growing on media lacking Trp, Leu, His, and Ade. Yeast DNA was recovered, and then transformed into Escherichia coli DH5a. Plasmids from positive clones were extracted, sequenced, and characterized.
Cell culture and transient transfections
COS-7 cells or HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum, penicillin (100 UÁmL -1 ), and streptomycin (100 mgÁmL -1 ). The cells were cultured at 37 8C in a 5% CO 2 incubator. Cells were transfected at 70% confluence using Sofast TM (Xiamen Sunma Biotechnology Co., Ltd.) according to the manufacturer's instructions.
Mammalian two-hybrid reporter assay
COS-7 cells (1 Â 10 5 cells per pole) were co-transfected with 0.1 mg pCMV-BD-YPEL4, 0.1 mg pCMV-AD-MVP, and 0.5 mg pFR-Luc reporter plasmid for 12 h. The COS-7 cells co-transfected with 0.1 mg pCMV-BD-YPEL4 and 0.5 mg pFR-Luc reporter plasmid were considered the control group. Cells were then grown in fresh DMEM for another 24 h. For luciferase activities assays, the cells were harvested and then lysed in 80 mL of reporter lysis buffer (Promega). Luciferase activity was measured by injection of luciferin into cell lysate using Turner Designs TD-20/20n. b-Galactosidase activity was measured by incubating 20 mL cell lysate with 20 mL b-galactosidase reaction buffer (200 mmolÁL -1 sodium phosphate buffer, 2 mmolÁL -1 MgCl 2 , l00 mmolÁL -1 b-mercaptoethanol, and 1.33 mgÁmL -1 o-nitrophenyl-b-galactopyranoside) at 37 8C for 30 min until a faint yellow color appeared. Reactions were stopped by addition of 50 mL of 1.0 molÁL -1 Tris. Finally, the solutions were analyzed using a spectrophotometer at 420 nm. Each experiment was performed in triplicate and each assay was repeated at least 3 times.
Immunofluorescence staining
COS-7 cells were transfected with pEGFP-YPEL4 and pCMV-Tag2B-MVP. After 48 h, cells were fixed with 4% paraformaldehyde for 15 min, and blocked with 2% fetal bovine serum in PBS (pH 7.4) for 30 min at room temperature. Cells were then incubated with monoclonal anti-Flag (Santa Cruz Biotechnology) for 1 h at room temperature. Cells were washed 3 times with PBS (pH 7.4), and subsequently incubated with Cy3-conjugated phalloidin anti-mouse IgG (Santa Cruz Biotechnology) for 1 h at room temperature. The cell nuclei were stained with 4',6'-diamidino-2-phenylindole hydrochloride (DAPI). Co-localization of the EGFPfused YPEL4 and Flag-fused MVP was detected using a Nikon inverted fluorescence microscope (Olympus, Tokyo, Japan).
Protein expression and purification of YPEL4 and antibody production
GST or GST-YPEL4 vector was transferred into E. coli BL21 (DE3). Isopropyl b-D-thiogalactopyranoside (IPTG) was added in exponentially growing bacterial cultures to a final concentraction of 0.1 mmolÁL -1 , and then the bacterium was incubated at 30 8C for 6 h. The collected fusion proteins were purified with glutathione -Sepharose 4B (Amersham Biosciences). The purified YPEL4 protein was immunized 3 times at intervals of 2 weeks into New Zealand white rabbits using Freund's complete adjuvant. The titer of antiserum was determined by Western blotting.
GST pull-down assay
GST or GST-YPEL4 fusion proteins were expressed and isolated. For the pull-down assay, 500 mg of the GST-YPEL4 and 500 mg of the Flag-MVP were mixed with 50 mL of 50% suspension of glutathione -Sepharose 4B beads for 2 h in 1 Â PBS. The mixture of 1 mg of the GST and 500 mg of the Flag-MVP incubated with glutathioneSepharose 4B beads was regarded as control group. Then, the beads were washed extensively and boiled. The binding proteins were resolved by 13% SDS-polyacrylamide gel and analyzed by Western blot with anti-Flag antibody (Santa Cruz Biotechnology) and horseradish peroxidase conjugated secondary antibody (Santa Cruz Biotechnology).
Co-immunoprecipitation
COS-7 cells were co-transfected with pCMV-Tag2B-YPEL4 and pCMV-Myc-MVP. After 48 h, the harvested cells were resuspended in RIPA buffer (50 mmolÁL -1 TrisHCl (pH 7.2), 150 mmolÁL -1 NaCl, 1% v/v Triton X-100, 1% w/v sodium deoxycholate, and 0.1% w/v SDS) with protease inhibitors. Co-immunoprecipitation was performed using 1 mg anti-Flag or anti-Myc antibody (Santa Cruz Biotechnology). Co-precipitated proteins were collected using protein-A/G -Sepharose, and were then analyzed by Western blotting using anti-Flag or anti-Myc antibody (Santa Cruz Biotechnology).
RNA i analysis and luciferase reporter assay
The sequences of a pair oligonucleotides were as follows: sense, 5'-GATCC AAACACGATGAGCTTATTTCAAGAG-AATAAGCTCATCGTGTTTGGTTTTTC-3'; antisense, 5'-TCGAGAAAAACCAAACACGATGAGCTTATTCTCTTG-AAATAAGCTCATCGTGTTTGGCGGG-3'. The oligos contained a 20 bp unique sequence derived from YPEL4 for suppression, and were cloned into the unique BglII and XhoI sites of pSuper vector to form a pSUPERRNAi-YPEL4 vector. For RNA interference, 100 nmolÁL -1 pSUPERRNAi-YPEL4 or control small interfering RNA (siRNA) was transfected into HeLa cells. After culturing for 24 and 36 h, cells were harvested and the total proteins were extracted. RNAi efficiency was detected using Western blot analysis by anti-YPEL4 antibody and horseradish peroxidase conjugated secondary antibody (Santa Cruz Biotechnology). The luciferase activity for pCMV-Tag2B, pCMV-Tag2B-YPEL4, pSuper, and pSuper-YPEL4 in HeLa cells was studied to investigate the effects of YPEL4 on transcriptional activity of Elk1 using the steps described previously.
Statistical analysis
The SPSS programe (version 12.0) was used to perform statistical analysis. One-way analysis of variance (ANOVA) was used to compare the mean differences in different Elk1activity groups, and the least significance difference (LSD) was used for multiple comparisons. The signifiance level was set at p = 0.05.
Results
Identification of MVP as a YPEL4-interacting protein
To identify YPEL4-interacting proteins, a human brain cDNA library in frame with the GAL4 activation domain was screened using pGBKT7-YPEL4 fused to the GAL4 binding domain as bait. Twenty-eight positive clones activating all 3 reporter genes (HIS3, URA3, and lacZ) were identified. The positive clones were picked and further confirmed by retransforming the recovered plasmids into the yeast strain containing the bait construct. Four plasmids were identified as the distinct clones. After sequence and BLAST analyses, a single open reading frame corresponding to the 1364 base pairs on the 3' end of MVP cDNA (GenBank accession No. NM005115) was characterized. This sequence matched the 445 amino acid residues in the Cterminal fragment of MVP.
Interaction of YPEL4 and MVP in mammalian cells
To demonstrate the interaction between YPEL4 and MVP in mammalian cells, we performed a mammalian two-hybrid assay. Thirty-six hours after transfection, luciferase activity was assayed. The luciferase activities of cells transfected with the pCMV-BD-YPEL4 expression vector were 3 times lower than those of cells co-transfected with both the pCMV-BD-YPEL4 and pCMV-AD-MVP. The results suggested that YPEL4 may interact with MVP in mammalian cells.
YPEL4 colocalizes with MVP in COS-7 cells
We next investigated whether these proteins were present in the same cellular region. pEGFP-N1-YPEL4 and FLAGtagged MVP were co-transfected into COS-7 cells. The images obtained with a Nikon inverted fluorescence microscope revealed that both EGFP-fused YPEL4 (Fig. 1A) and Flag-tagged MVP (Fig. 1B) were localized close to the mitotic apparatus in the mitotic phase. After overlay, colocalized signals (yellow) were clearly observed (Fig. 1D) . These results further confirmed the presence of YPEL4 and MVP in the same region.
Interaction of YPEL4 with MVP in vitro and in vivo
To further confirm the interaction of YPEL4 with MVP, we performed in vitro and in vivo binding experiments. First, we performed a GST pull-down assay to address whether YPEL4 can bind to MVP in vitro. GST-fused YPEL4 and GST alone were immobilized separately on glutathione-Sepharose beads, which were incubated with lysates of COS-7 cells overexpressing Flag-tagged MVP. Western blotting showed that Flag-MVP was pulled down by GST-YPEL4, but not by GST alone, indicating that MVP binds to YPEL4 in vitro (Fig. 2B) . Second, the interaction of YPEL4 with MVP was demonstrated by co-immunoprecipitation experiments. Western blotting indicated that MVP was co-precipitated with anti-FLAG antibody, and YPEL4 was also co-precipitated with anti-Myc antibody ( Fig. 2A) . These results demonstrated that YPEL4 can interact with MVP both in vivo and in vitro, which suggests that endogenous proteins exist in a protein complex in cells.
MVP suppresses YPEL4-induced activation of Elk-1
Previous studies have implicated that MVP, in a complex with Erk, regulated Elk-1 activity in the MAPK signaling pathway (Gille et al. 1995) . Since YPEL4 interacted with MVP in this study, we next examined the role of YPEL4 and the effect of interaction of YPEL4 with MVP on regulation of the Elk-1 activity in the MAPK signaling pathway. To study YPEL4 function, GST-YPEL4 proteins were expressed in E. coli BL21, and the proteins produced were detected using Western blotting (Fig. 2C) . Expression of YPEL4 was decreased by co-transfection of pSUPERRNAi-YPEL4 in HeLa cells (Fig. 2D) . Over-expression of YPEL4 increased Elk-1 activity (5-fold), whereas the Elk-1 luciferase activity was inhibited when pCMV-Tag2B-YPEL4 cotransfected with pSUPERRNAi-YPEL4 (Fig. 3B) . The luciferase activity differences between different groups were significant (p < 0.001), and the multiple comparsion indicated the differences existed mainly between the pCMVTag2B-YPEL4 group and the others (p < 0.001). Finally, pCMV-Tag2B-YPEL4 co-transfected with pCMV-Tag2B-MVP substantially reduced YPEL4's ability to activate Elk-1 (Fig. 3C) . The results demonstrated that MVP suppressed YPEL4-mediated Elk-1 activities.
Discussion
One hallmark of a developmentally important gene is that it is conserved throughout evolution. YPEL proteins have been conserved for a considerable length of time, with a metal-binding pocket that could bind zinc (or another metal ion) and form a structural intermediate between a GAL4 DNA-binding domain and a RING finger (Farlie et al. 2001) . Although Roxström-Lindquist and Faye (2001) have identified a specific interaction between Drosophila YPEL1 and Hemolin, the molecular mechanisms of YPEL proteins require further elucidation. We first identified MVP as a binding partner of YPEL4, and like the YPEL proteins, MVP is highly evolutionarily conserved. MVP represents the main component of vault ribonucleoprotein particles, which have been found in species as diverse as the slime mold Dictyostelium discoideum, electric ray, sea urchin, and mammals, indicating its essential cellular function in organisms. Although the precise function of vaults is not yet determined, MVP has been implicated in a variety of cellular processes including drug resistance, subcellular transport, and cell differentiation (Mossink et al. 2003) by regulating intracellular signaling cascades including the phosphoinositide 3-kinase/Akt (PI 3-kinase/Akt) signaling pathway (Yu et al. 2002) , the MAP kinase pathway (Kolli et al. 2004) , and the IFN-g-induced JAK/STAT pathway (Steiner et al. 2006) . Therefore, interactions between MVP and YPEL4 in this study suggest the molecular functions of YPEL4 might be relevant to signaling pathways mediated by MVP.
Searching for the underlying mechanisms, we set out to analyze the relationship between YPEL4 activity and the mitogen-activated protein kinase (MAPK) signal transduction pathway, which is one of the most widespread mechanisms of eukaryotic cell regulation. The most studied targets of MAPK signaling pathways are transcription factors, such as c-Jun and Elk-1, which regulate transcription immediate early gene expression through binding to the serum response element (SRE). It has previously been demonstrated that MVP participates in MAPK signaling pathways and that MVP interacts with the activated form of the extracellularregulated kinases (Erks) in response to EGF. Tyrosylphosphorylated MVP forms a constitutive complex with SHP-2 and the Erks, thus regulating the activation of the Ras-MAP kinase pathway (Kolli et al. 2004) . By performing pathway-specific reporter gene assays, we found that overexpression of YPEL4 increased Elk-1 activity, whereas knock down of endogenous YPEL4 by siRNA resulted in a decreased Elk-1 activity. Furthermore, we found that MVP substantially reduced YPEL4's ability to activate Elk-1. Hence, the results suggest that YPEL4 might be a novel member of a complex between MVP and SHP-2 or a new branch of the MVP-mediated MAPK signaling pathway (Fig. 3D) .
Our results may also suggest functions of YPEL4. First, the subcellular localization assay revealed that YPEL4 proteins were located on or close to the mitotic apparatus during mitosis, but are localized to the nuclei and nucleoli during interphase, suggesting YPEL4 proteins play roles in mitosis-associated functions (Hosono et al. 2004) . Also, vaults are present in a wide range of cell types at numbers of over 10 4 particles per cell (Kickhoefer et al. 1998) . The localization of vaults in mammalian cells is mainly cytoplasmic, and a small portion was also found to be associated Kolli et al. (2004). with the nuclear membrane (Chugani et al. 1993 ). Hamill and Suprenant (1997) identified the MVP in sea urchins as a 107 kDa polypeptide that copurifies with microtubules, which are major components of the mitotic apparatus. The results in this study indicated both YPEL4 and MVP were co-localized on or close to the mitotic apparatus of cells. Thus, YPEL4 interacting with MVP may play an important role in cellular survival by regulating cell division. Second, MVP has been independently reported to be over-expressed in various kinds of cancer cells and participates in anticancer drug resistance and oncogenic processes. Elucidation of the interactions between YPEL4 and MVP should be very important in deciphering their pathophysiological roles in anticancer drug resistance and cancer progression.
